Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results. [PDF]
Mason-Osann E +3 more
europepmc +1 more source
Novel PE-DT-fusion toxin enhances internalization and target-dependently restores the cytotoxicity of recombinant immunotoxins. [PDF]
Fischer C +7 more
europepmc +1 more source
Bivalent CD47 Immunotoxin for Targeted Therapy of Lung Cancer. [PDF]
Ma J +13 more
europepmc +1 more source
Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo. [PDF]
Mazor R +5 more
europepmc +1 more source
Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study. [PDF]
Klimczak A +11 more
europepmc +1 more source
Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin. [PDF]
Wang Z +8 more
europepmc +1 more source
Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity. [PDF]
Kreitman RJ +7 more
europepmc +1 more source
Designing a Novel Immunotoxin against Prostate Cancer based on PE40 Toxin: An <i>In silico</i> Approach. [PDF]
Azdoo S +5 more
europepmc +1 more source
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. [PDF]
Mazor R +13 more
europepmc +1 more source

